late in the stromal fraction that contains mitochondria, nor does 59Fe accumulate in the nonheme cytosolic fraction. Hence, the defect in the Belgrade rat reticulocyte occurs in the endocytic vesicle or in a step subsequent to iron transit from the vesicle but before the nonheme cytosolic or mitochondrial iron fractions. Therefore, the mutation affects either the release of iron from transferrin or iron transport from the vesicle to the mitochondrion. 0 1993 by The American Society of Hematology.
heme contains Fe2+; thus, reduction of Fe3+ to Fe2+ must also be occurring, probably in the mitochondrion.
Succinylacetone (4,6-dioxoheptanoic acid) is an inhibitor of heme synthesis that decreases production of porphobilinogen by acting on the enzyme 8-aminolevulinic acid dehydrase." When normal rat or rabbit reticulocytes were incubated in the presence of succinylacetone, iron incorporation into heme was blocked,11s12 whereas iron incorporation into cells continued unabated or at even higher levels, leading to accumulation of nonheme iron in the stromal fraction,L1s12 specifically in the inner mitochondrial membrane." The accumulated iron was chased into heme when succinylacetone inhibition was relieved. Adams et all' also showed iron accumulated in a cytosolic nonheme intermediate of 8 to 13
Kd that exhibited absorbance at 280 nm. They postulated it to be a putative cytosolic iron transporter. The '9Fe found associated with this carrier could be chased into heme in the absence of succinylacetone or into mitochondria in the presence of succinylacetone."
We have examined the effects of inhibition of heme synthesis on intracellular distribution of iron in Belgrade reticulocytes incubated with succinylacetone to localize the site where iron delivery from transferrin is defective. We find that iron does not accumulate in Belgrade mitochondria during such incubations nor does labeled iron increase in the cytosolic nonheme iron fraction, including the putative cytosolic transporter. Therefore, we conclude that the Belgrade defect is manifest in the endocytic vesicle or at a step of iron delivery subsequent to iron transit from the vesicle. In either case, iron reaches the mitochondrion at a diminished rate.
MATERIALS AND METHODS
Normal rats (+/!I or +/?where ? is either + or b) were bled on days 7, 5, and 3 preceding the experiments to induce a reticulocytosis of about 20%. Calculated iron loss was replaced by an intramuscular injection of iron dextran. Belgrade rats (b/b) had a naturally occumng reticulocytosis of about 20%. Blood was collected by retro-orbital sinus puncture after ether anesthesia. The SUNY Institutional Animal Care and Use Committee reviewed and approved all procedures on animals.
Rat transferrin was purchased from Pel-Freez Biologicals (Rogers, AR), depleted of endogenous iron, and loaded with 59Fe using the nitrilotriacetic acid method.' A portion of the 59Fe-transfemn was then labeled with Na? (0.5 mCi; 100 mCi/mL; ICN Radiochemicals, Irvine, CA) was mixed with 10 mg of 59Fe-transferrin and an Enzymobead single reaction radioiodina-
Animals.
Transferrin. Samples were separated into cytosol and stroma by centrifugation of lysates at 300,OOOg-minute at 4°C in a JA-20 rotor (Beckman, Palo Alto, CA) (for volumes > 1.5 mL) or in a Hermle microfuge (for volumes I 1.5 mL). Heme was extracted from both cytosol and stroma by the oxalic acid-acetone meth~d.'~ FPLC analysis of stroma-free cytosol was performed on a 1 X 30 cm column of Superose-12 (Pharmacia-LKB, Piscataway, NJ), equilibrated with 5 mmol/L Tris-HCI, 0.1 mol/L NaCI, pH 8.6, and eluted at 4°C at a flow rate of 1 mL/min. Fractions were collected every 0.5 minutes. Samples, which were lysed with 5 mmol/L Tris-HC1, pH 8.6, were made 0.1 mol/L in NaCl before loading. 59Fe CPM and "' I-CPM were measured in an LKB Compugamma counter. RNA was determined as previously described3; because of uncertainties and imprecision in counting reticulocytes, comparisons between Belgrade and control rats were based on RNA denominators. Data were analyzed on an AT compatible computer using the program STATA (Computing Resource Center, Los Angeles, CA), taking P 5 .05 to be significant.
Sample analysis.

RESULTS
Subcellular iron distribution.
Succinylacetone alters subcellular iron distribution in reticulocytes. Figure 1 illustrates the time dependence of iron incorporation into subcellular fractions and, via duplicate samples, the reproducibility within one experiment. Table 1 presents rates of iron incorporation and an evaluation of which differences were significant. These data confirm prior observations on differences between Belgrade and normal reticulocytes3 and on the effects of succinylacetone on heme synthesis and iron uptake." The rate of b/b cellular iron incorporation is less than 20% of the +/? rate3 in the absence of succinylacetone. In normal (+/?) reticulocytes, succinylacetone stimulates the rate of iron incorporation 1.5-fold." Succinylacetone blocks heme synthesis in normal reticulocytes and also blocks normal cytosolic incorporation with a more than compensating increase in stromal incorporation. This redistribution has been shown to be due to mitochondrial iron accumulation.
Succinylacetone affects iron uptake and distribution in Belgrade reticulocytes differently than in normal cells ( Fig  IC and D and Table 1 ). Total cellular incorporation does not increase significantly with succinylacetone. Although succinylacetone inhibits Belgrade heme synthesis, the redistribution of iron between cytosol and stroma is much less striking. For example, normal reticulocytes exhibit a 15-fold stimulation in stromal incorporation when exposed to 1 mmol/L succinylacetone, but Belgrade cells show a less than twofold increase that is not statistically significant and does not compensate for the decrease in cytosolic incorporation. Nevertheless, both stromal and cytosolic incorpora- The ratio of 59Fe:'251 in the stromal fraction aids in determining when stromal iron incorporation exceeds the level that can be contributed by difemc transferrin. Figure 3 gives the molar ratio of 59Fe:'251 with time for the stromal fraction from the experiment in Fig 1. Extrapolation of each incubation to 0 time gives a molar ratio of about 2.0, representing the binding of diferric transferrin to receptors on the plasma membrane. In +/? stroma with 1 mmol/L succinylacetone, the molar ratio increases about 15-fold from 2.0 to 30.0 after 1 hour of incubation (Fig 3B) . Hence, most of the stromal iron under these conditions is not associated with transfemn. In similar studies of normal rat reticulocytes," this iron was found in the inner membrane of mitochondria. In +/? stroma without succinylacetone, the ratio goes up to 5.0 after 1 hour of incubation, indicating some nontransferrin iron associated with the stroma (Fig 3A) . This iron is nonheme iron because we measured and corrected for heme iron in the stroma. In b/b stroma without succinylacetone, the ratio stays flat with
Stromal iron.
For time (Fig 3C) , whereas in the presence of 1 mmol/L succinylacetone, the ratio increases only slightly to 4.0 (Fig 3D) . Therefore, these results suggest that transport of iron to the mitochondria in Belgrade reticulocytes is deficient. Figure 4 presents nonheme 59Fe in the cytosol as a function of time. There is a small amount of incorporation (-4 CPM/pg RNA at 15 minutes) which increases threefold from 15 to 60 minutes in normal reticulocytes without succinylacetone (Fig 4A) . This incorporation is much more pronounced in the presence of 1 mmol/L succinylacetone (Fig 4B) going from -8.5 to 30 CPM/Kg RNA over the same interval. In b/b reticulocytes there is minimal cytosolic nonheme 59Fe incorporation over time either without (Fig 4C) or with (Fig 4D) 1 mmol/L succinylacetone. This observation strongly suggests that the b/b defect prevents accumulation of cytosolic nonheme iron and is thus at or before this putative intermediate in the pathway of iron metabolism.
The effect of succinylacetone treatment on the 8-to 13-Kd iron carrier known to be present in the cytosolic nonheme fraction from normal reticulocytes has been docu-
Nonheme cytosolic iron.
mented by FPLC analyses on Superose-12 (Fig 5) . s9Fe counts are found in the 8-to 13-Kd region in both +/b ( Fig  5A) and b/b (Fig 5B) reticulocytes, but the sum ofthe counts in this region from Belgrade cytosol is 20% the sum from +/b cytosol. Although this region contains material with absorbance at 280 nm, it has no absorbance at 415 nm (not shown; Adams et all'). 59Fe-transferrin is detected in the cytosol of both +/b and b/b reticulocytes (Fig 5A and B) , perhaps coming from endosomes not pelleted with the stroma. Heme synthesis is inhibited by succinylacetone to similar nearly undetectable levels in the two types of cells (~3 % in +/b reticulocytes and < 10% in b/b reticulocytes, relative to the controls, with the difference due to the uninhibited rate being higher in the +/b cells); hence, 59Fe in hemoglobin is negligible. A reciprocal relationship is found between "Fe counts associated with transferrin and 59Fe counts in the 8-to 13-Kd region. For +/b cytosol, 27% of the 59Fe counts are in the transferrin peak and 73% are in the second peak corresponding to the putative cytosolic transporter. For b/b cytosol, 79% of the counts are in the transferrin peak, but only 2 1 % in the putative transporter peak. 
DISCUSSION
Iron uptake into Belgrade reticulocytes is defective (Fig  1A v C; Edwards et a13) . The purpose ofthe present study is to localize the defect more precisely by inhibiting heme synAlterations in intracelliilar iron distribution. 
Genotype & [Succinylacetone]
For rat reticulocytes, as shown previously by Adams et al," succinylacetone inhibition of heme synthesis causes an accumulation of iron in the mitochondria that is associated with the stromal fraction (Figs 1 B and 2 and Table 1 ). In normal reticulocytes, the functional integrity of the iron delivery process in succinylacetone-inhibited cells leads to continued iron release from transferrin, resulting in increased iron loading of mitochondria and detection of 59Fe in the stroma (Fig 3B and Adams et all') . However, in Belgrade reticulocytes, stromal iron in cells treated with succinylacetone is decreased from 4-to 10-fold relative to normal cells ( Figs  1D and 2 and Table 1 ) and much of the iron is not found in mitochondria (Fig 3) . These findings are consistent with the existence of a defect in the iron delivery pathway leading to the mitochondria. This conclusion involves assumptions that the stromal fraction contains mitochondrial iron in nearly quantitative recovery and that there is minimal contamination of cytosolic by stromal iron and vice versa. Mitochondrial 59Fe counts appear at the void volume of Fig 5; we calculate that these fractions contain less than 6% of the counts recovered and less than 5% of total mitochondrial label. Similar calculations on fractions from differential centrifugation, mixing experiments, or sucrose or Percoll gradients (not shown) indicate that the stromal fraction contained nearly all of the mitochondrial iron and that cross-contamination of stromal and cytosolic fractions was generally 5 5 % and always less than 10%. Succinylacetone stimulates cellular iron incorporation in normal rat and rabbit reticulocytes."~L23'6,'7 W e confirm this stimulation for normal cells (Figs I B and 2 and Table I ), but did not observe stimulation of iron uptake in Belgrade reticulocytes ( Figs ID and 2 and Table 1 deficiency or the deficiency in iron transport may be so overwhelming as to obscure the effects of hemin.
Iron flux through a nonheme cytosolicfraction. Not all cytosolic iron is heme iron (Figs 1, 2, 4 , and 5). Some of it exists in a nonheme form. In rat reticulocytes, this iron is mainly associated with an 8-to 13-Kd peak, but not with ferritin." When heme synthesis is inhibited with succinylacetone, iron associated with the nonheme cytosolic fraction increases in normal rat reticulocytes (Fig 4B) , but not in Belgrade reticulocytes (Fig 4D) . A similar component is also detectable in +/? reticulocytes in the absence of inhibitor, albeit less easily (Fig 4A) , but nonheme cytosolic iron is minimal in uninhibited b/b cells (Fig 4C) .
Using the study of Adams et all' as a model, we examined the nature of the nonheme cytosolic iron by FPLC. In Fig 5 , we show that 59Fe accumulates in a peak of similar size in both Belgrade and normal cytosol. Adams et al" showed that 59Fe counts in this nonheme iron 8-to 13-Kd fraction could be chased into the mitochondrial fraction, behavior consistent with its being an intermediate in heme synthesis. However, this peak from Belgrade cytosol contains only 20% of the iron found in cytosol from normal rat reticulocytes. Multiple components in the 8-to 13-Kd region of the A, , , trace have been resolved in Fig 5 and a few other separations but not in all analyses (not shown). Separation inconsistencies make it difficult to compare the quantities of this component in Belgrade and normal cytosol. Also, the quantity of this putative carrier could be responsive to the amount of iron available in the cell with low intracellular iron leading to a decreased amount of the camer. Flux into this putative intermediate in Belgrade reticulocytes is only 20% of normal, suggesting that the block is proximal to this fraction.
Previously, we5 showed that Fe-SIH alleviates both the deficiency in iron flux in Belgrade reticulocytes and diminished porphyrin synthesis. Recovery of the capacity for heme synthesis in this fashion led us to argue that the Belgrade defect is not in porphyrin synthesis. In the present study, inhibition of porphyrin synthesis by succinylacetone leads to accumulation of nonheme iron in mitochondria of normal reticulocytes," but this "stromal" accumulation is greatly de-
Porphyrin synthesis and the Belgrade anemia.
For personal use only. on August 30, 2017. by guest www.bloodjournal.org From Table 1 ). These data not only distinguish the Belgrade anemia from sideroblastic anemia but also show that b/b reticulocytes lack the ability to acquire a siderosis. This compafison attributable to defective heme ~ynthesis.~ Based on the data in this report and our previous work, the Belgrade defect occurs in or immediately after the vesicle. Using fluorescently tagged transfemn, we have presented preliminary data that Belgrade reticulocytes appear to be defective in endosomal acidification,20,21 which would be consistent with poor release of iron from transfemn. Further studies are in progress in Belgrade cells. Determining the location of the Belgrade defect is likely to identify a previously ill-defined step in erythroid iron metabolism.
